Back
Ascendis Pharma AS Stock Price Chart

Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
ASND
Ascendis Pharma AS
Last Price:
$142.85
Seasonality Move:
-2.3%
7 Day Trial
ALL ACCESS PASS
$
7

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing slight selling pressure.
Ascendis Pharma AS Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 152.89 | Sell |
20-day SMA: | 156.39 | Sell |
50-day SMA: | 145.36 | Sell |
200-day SMA: | 136.16 | Buy |
8-day EMA: | 151.97 | Sell |
20-day EMA: | 153.93 | Sell |
50-day EMA: | 148.58 | Sell |
200-day EMA: | 137.67 | Buy |
Ascendis Pharma AS Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.51 | Buy |
Relative Strength Index (14 RSI): | 39.11 | Sell |
Chaikin Money Flow: | -125653 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (148.73 - 162.87) | Sell |
Bollinger Bands (100): | (126.1 - 151.68) | Buy |
Ascendis Pharma AS Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Ascendis Pharma AS Stock
Is Ascendis Pharma AS Stock a Buy?
-
Ascendis Pharma AS share price is 142.67 while ASND 8-day simple moving average is 152.89, which is a Sell signal.
-
The stock price of ASND is 142.67 while Ascendis Pharma AS 20-day SMA is 156.39, which makes it a Sell.
-
Ascendis Pharma AS 50-day simple moving average is 145.36 while ASND share price is 142.67, making it a Sell technically.
-
ASND stock price is 142.67 and Ascendis Pharma AS 200-day simple moving average is 136.16, creating a Buy signal.
ASND Technical Analysis vs Fundamental Analysis
Sell
20
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy or a Sell?
-
Ascendis Pharma AS stock is rated a SellThe current Ascendis Pharma AS [ASND] share price is $142.67. The Score for ASND is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Ascendis Pharma AS Stock Info
Market Cap:
8.6B
Price in USD:
142.67
Share Volume:
578.6K
Ascendis Pharma AS 52-Week Range
52-Week High:
169.37
52-Week Low:
111.09
Sell
20
Ascendis Pharma AS (ASND)
is a Sell
Ascendis Pharma AS Share Price Forecast
-
What is the Ascendis Pharma AS stock price today?The Ascendis Pharma AS stock price is 142.67 USD today.
-
Will ASND stock go up or go down?Ascendis Pharma AS> share price is forecast to RISE/FALL based on technical indicators
-
Is Ascendis Pharma AS overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ascendis Pharma AS is overvalued.
Is Ascendis Pharma AS Stock a Buy?
-
Ascendis Pharma AS share price is 142.67 while ASND 8-day exponential moving average is 151.97, which is a Sell signal.
-
The stock price of ASND is 142.67 while Ascendis Pharma AS 20-day EMA is 153.93, which makes it a Sell.
-
Ascendis Pharma AS 50-day exponential moving average is 148.58 while ASND share price is 142.67, making it a Sell technically.
-
ASND stock price is 142.67 and Ascendis Pharma AS 200-day simple moving average is 137.67, creating a Buy signal.
Fundamental Analysis of Ascendis Pharma AS
Is Ascendis Pharma AS a good investment?
-
Analysts estimate an earnings increase this quarter of $0.81 per share, an increase next quarter of $0.04 per share, an increase this year of $3.20 per share, and an increase next year of $5.33 per share.
Technical Analysis of Ascendis Pharma AS
Should I short Ascendis Pharma AS stock?
-
ASND Moving Average Covergence Divergence (MACD) indicator is 0.51, suggesting Ascendis Pharma AS is a Buy
-
Ascendis Pharma AS Relative Strength Index (RSI) is 39.11, which suggest Ascendis Pharma AS is oversold
-
The Bollinger Bands (25) for Ascendis Pharma AS is (148.73 - 162.87), which suggest Ascendis Pharma AS is a Buy
-
The Bollinger Bands (100) for Ascendis Pharma AS is (126.1 - 151.68), which suggest Ascendis Pharma AS is a Buy
* Ascendis Pharma AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.